We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Remdesivir

News List

COVID-19: Gilead deals with ‘overwhelming’ remdesivir demands, Eli Lilly halts trial enrolment pharmatimes
March 25, 2020
As the UK comes to terms with significantly stricter lockdown rules this morning, following prime minister Boris Johnson’s speech last night ...
Gilead halts emergency access to remdesivir in Covid-19 indication pharmaceutical-technology
March 24, 2020
Gilead Sciences has announced a temporary halt to emergency access to its investigational Covid-19 drug remdesivir due to rising demand.
Gilead's Remdesivir Shows Promise in COVID-19 contractpharma
March 16, 2020
According to a World Health Organizationofficial, Gilead's experimental antiviral drug remdesivir, to date, shows the most promise for treating COVID-19 disease.
NIAID Began First Clinical Trial of Remdesivir in the U.S. Lin Zhang
March 03, 2020
An Investigational New Drug Application (IND) Remdesivir is developed by American drugmaker Gilead Sciences Inc..
Experimental antiviral Drug Remdesivir recognized as potential treatment for 2019-nCov PharmaSources
February 10, 2020
Remdesivir, an experimental antiviral drug, has been recognized as a potential treatment against the 2019 novel-Coronavirus (2019-nCov) recently outbreaks in China and around the world.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page